Cetuximab in Combination With Anti-PD-1 and mFOLFOX Treat For RAS/BRAF wt Right-Sided Colon Cancer
Phase 2
Recruiting
- Conditions
- Colonic Neoplasms
- Interventions
- Combination Product: neoadjuvant chemotherapy
- First Posted Date
- 2022-07-21
- Last Posted Date
- 2022-07-21
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 66
- Registration Number
- NCT05468177
- Locations
- 🇨🇳
Tongji Hospital, Huazhong University of Science and Technology, Wuhan, Hubei, China
A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve
- First Posted Date
- 2022-07-15
- Last Posted Date
- 2022-10-20
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 100
- Registration Number
- NCT05459493
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
A Novel MSE Score to Predict rHCC Patients
Completed
- Conditions
- HCC
- Interventions
- Procedure: hepatectomy
- First Posted Date
- 2022-07-11
- Last Posted Date
- 2022-07-11
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 300
- Registration Number
- NCT05450874
A Cross-sectional Study to Evaluate Speech and Language Development in Chinese Children Aged 2-6 Years
- Conditions
- Mental RetardationAttention Deficit Hyperactivity DisorderAutism Spectrum Disorder
- Interventions
- Other: establish a new Chinese children's speech and language norm
- First Posted Date
- 2022-07-01
- Last Posted Date
- 2022-07-01
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 5744
- Registration Number
- NCT05442229
Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC
- Conditions
- Hepatocellular CarcinomaProgrammed Cell Death 1Effects of Immunotherapy
- Interventions
- First Posted Date
- 2022-06-15
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05420922
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF)
Not Applicable
- Conditions
- Paroxysmal Atrial Fibrillation
- Interventions
- Device: Pulsed Field Ablation
- First Posted Date
- 2022-06-02
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 144
- Registration Number
- NCT05400928
- Locations
- 🇨🇳
Tongji Hospital, Wuhan, Hubei, China
Hepatectomy for Early-stage HCC Patients With CSPH
Completed
- Conditions
- Portal HypertensionHCC
- Interventions
- Procedure: hepatectomy
- First Posted Date
- 2022-06-02
- Last Posted Date
- 2022-06-02
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 320
- Registration Number
- NCT05402644
Hetrombopag for Lower-risk MDS With Thrombocytopenia: a Prospective，Open-label, Single-arm Study.
- First Posted Date
- 2022-05-26
- Last Posted Date
- 2022-05-26
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 28
- Registration Number
- NCT05392647
Radiomics Based Multimodal Transvaginal Ultrasound Imaging in Endometrial Cancer
- Conditions
- Cervical Stromal InvasionTransvaginal UltrasoundEndometrial Cancer
- Interventions
- Diagnostic Test: radiomics
- First Posted Date
- 2022-05-24
- Last Posted Date
- 2022-05-24
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 2000
- Registration Number
- NCT05387460
- Locations
- 🇨🇳
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Application of Carbon Dioxide for Identifying the Intersegmental Plane in Thoracoscopic Segmentectomy
Not Applicable
Completed
- Conditions
- Pulmonary Nodule, SolitarySegmentectomyLung CancerPulmonary Nodule, Multiple
- Interventions
- Procedure: 100% oxygenProcedure: Carbon dioxide
- First Posted Date
- 2022-04-27
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- Tongji Hospital
- Target Recruit Count
- 52
- Registration Number
- NCT05350137
- Locations
- 🇨🇳
Tongji hospital, Wuhan, Hubei, China
© Copyright 2025. All Rights Reserved by MedPath